| [1] |
Crome L．Abnormal brain structure in mental deficiency[J]．Med World，1957，86(3): 217-223.
|
| [2] |
Crino PB.mTOR: A pathogenic signaling pathway in developmental brain malformations[J]． Trends Mol Med， 2011， 17(12): 734-742.DOI: 10.1016/j.molmed.2011.07.008. |
| [3] |
Jansen LA, Mirzaa GM, Ishak GE, et al. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia[J]． Brain， 2015， 138(Pt 6): 1613-1628.DOI: 10.1093/brain/awv045. |
| [4] |
Zhou J, Blundell J, Ogawa S，et al.Pharmacological inhibition of mTORC1 suppresses anatomical，cellular，and behavioral abnormalities in neural-specific Pten knock-out mice[J]． J Neurosci， 2009， 29(6): 1773-1783.DOI: 10.1523/JNEUROSCI. |
| [5] |
Lin YX, Lin K, Liu XX，et al.PI3K-AKT pathway polymerase chain reaction (PCR) array analysis of epilepsy induced by type II focal cortical dysplasia[J]． Genet Mol Res， 2015， 14(3): 9994-10000.DOI: 10.4238/2015. |
| [6] |
D′Gama AM, Woodworth MB, Hossain AA，et al.Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias[J]． Cell Rep， 2017， 21(13): 3754-3766.DOI: 10.1016/j.celrep.2017.11.106. |
| [7] |
Pelorosso C, Watrin F, Conti V，et al.Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy[J]． Hum Mol Genet， 2019， 28(22): 3755-3765.DOI: 10.1093/hmg/ddz194. |
| [8] |
Dawson RE, Nieto Guil AF, Robertson LJ，et al.Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy[J]． Neurobiol Dis， 2020(134): 104640.DOI: 10.1016/j.nbd.2019.104640. |
| [9] |
|
| [10] |
Meng XF, Yu JT, Song JH, et al. Role of the mTOR signaling pathway in epilepsy[J]． J Neurol Sci， 2013， 332(1-2): 4-15.DOI: 10.1016/j.jns.2013.05.029. |
| [11] |
|
| [12] |
Weckhuysen S, Marsan E, Lambrecq V, et al. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia[J]． Epilepsia， 2016， 57(6): 994-1003.DOI: 10.1111/epi.13391. |
| [13] |
Iffland PH 2nd, Carson V, Bordey A，et al.GATORopathies：the role of amino acid regulatory gene mutations in epilepsy and cortical malformations[J]． Epilepsia， 2019， 60(11): 2163-2173.DOI: 10.1111/epi.16370. |
| [14] |
Dibbens LM, de Vries B, Donatello S，et al.Mutations in DEPDC5 cause familial focal epilepsy with variable foci[J]． Nat Genet， 2013， 45(5): 546-551.DOI: 10.1038/ng.2599. |
| [15] |
Scheffer IE, Heron SE, Regan BM，et al.Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations[J]． Ann Neurol， 2014， 75(5): 782-787.DOI: 10.1002/ana.24126. |
| [16] |
Ricos MG, Hodgson BL, Pippucci T，et al.Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy[J]． Ann Neurol， 2016， 79(1): 120-131.DOI: 10.1002/ana.24547. |
| [17] |
Baldassari S, Picard F, Verbeek NE，et al.Correction: the landscape of epilepsy-related GATOR1 variants[J]． Genet Med， 2019， 21(8): 1896.DOI: 10.1038/s41436-018-0325-9. |
| [18] |
Sim JC, Scerri T, Fanjul-Fernández M, et al. Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3[J]． Ann Neurol， 2016， 79(1): 132-137.DOI: 10.1002/ana.24502. |
| [19] |
Scerri T, Riseley JR, Gillies G，et al.Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5[J]． Ann Clin Transl Neurol， 2015， 2(5): 575-580.DOI: 10.1002/acn3.191. |
| [20] |
Crino PB.mTOR signaling in epilepsy：insights from malformations of cortical development[J]． Cold Spring Harb Perspect Med， 2015， 5(4): a022442.DOI: 10.1101/cshperspect. |
| [21] |
Nguyen LH, Mahadeo T, Bordey A. mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia[J]． J Neurosci， 2019， 39(14): 2762-2773.DOI: 10.1523/JNEUROSCI.2260-18.2019. |
| [22] |
|
| [23] |
Lim JS, Gopalappa R, Kim SH，et al.Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia[J]． Am J Hum Genet， 2017， 100(3): 454-472.DOI: 10.1016/j.ajhg.2017.01.030. |
| [24] |
Kotulska K, Jurkiewicz E, Domańska-Pakieła D，et al.Epilepsy in newborns with tuberous sclerosis complex[J]． Eur J Paediatr Neurol， 2014， 18(6): 714-721.DOI: 10.1016/j.ejpn.2014.06.009. |
| [25] |
Hoelz H, Coppenrath E, Hoertnagel K, et al. Childhood-onset epileptic encephalopathy associated with isolated focal cortical dysplasia and a novel TSC1 germline mutation[J]． Clin EEG Neurosci， 2018， 49(3): 187-191.DOI: 10.1177/1550059417697841. |
| [26] |
Dixit AB, Sharma D, Tripathi M，et al.Genome-wide DNA methylation and RNAseq analyses identify aberrant signalling pathways in focal cortical dysplasia (FCD) type II[J]． Sci Rep， 2018， 8(1): 17976.DOI: 10.1038/s41598-018-35892-5. |
| [27] |
Parker WE, Orlova KA, Heuer GG, et al. Enhanced epidermal growth factor，hepatocyte growth factor，and vascular endothelial growth factor expression in tuberous sclerosis complex[J]． Am J Pathol， 2011， 178(1): 296-305.DOI: 10.1016/j.ajpath.2010.11.031. |
| [28] |
Xu B, Michalski B, Racine RJ，et al.Continuous infusion of neurotrophin-3 triggers sprouting，decreases the levels of TrkA and TrkC，and inhibits epileptogenesis and activity-dependent axonal growth in adult rats[J]． Neuroscience， 2002， 115(4): 1295-1308.DOI: 10.1016/s0306-4522(02)00384-6. |
| [29] |
Pönniö T, Conneely OM.nor-1 regulates hippocampal axon guidance，pyramidal cell survival，and seizure susceptibility[J]． Mol Cell Biol， 2004， 24(20): 9070-9078.DOI: 10.1128/MCB.24.20.9070-9078.2004. |
| [30] |
Kuchukhidze G, Wieselthaler-Hölzl A, Drexel M，et al.Calcium-binding proteins in focal cortical dysplasia[J]． Epilepsia， 2015， 56(8): 1207-1216.DOI: 10.1111/epi.13053. |
| [31] |
Blauwblomme T, Dossi E, Pellegrino C，et al.Gamma-aminobutyric acidergic transmission underlies interictal epileptogenicity in pediatric focal cortical dysplasia[J]． Ann Neurol， 2019， 85(2): 204-217.DOI: 10.1002/ana.25403. |
| [32] |
Talos DM, Sun H, Kosaras B，et al.Altered inhibition in tuberous sclerosis and type Ⅱb cortical dysplasia[J]． Ann Neurol， 2012， 71(4): 539-551.DOI: 10.1002/ana.22696. |
| [33] |
Sakakibara T, Sukigara S, Otsuki T，et al.Imbalance of interneuron distribution between neocortex and basal ganglia: consideration of epileptogenesis of focal cortical dysplasia[J]． J Neurol Sci， 2012， 323(1-2): 128-133.DOI: 10.1016/j.jns.2012.08.035. |
| [34] |
Han P, Welsh CT, Smith MT，et al.Complex patterns of GABAergic neuronal deficiency and type 2 potassium-chloride cotransporter immaturity in human focal cortical dysplasia[J]． J Neuropathol Exp Neurol， 2019， 78(4): 365-372.DOI: 10.1093/jnen/nlz009. |
| [35] |
Zhong S, Zhao Z, Xie W，et al.GABAergic Interneuron and neurotransmission are mTOR-dependently disturbed in experimental focal cortical dysplasia[J]． Mol Neurobiol， 2021， 58(1): 156-169.DOI: 10.1007/s12035-020-02086-y. |
| [36] |
Birnbaumer L．The TRPC class of ion channels: a critical review of their roles in slow，sustained increases in intracellular Ca(2+) concentrations[J]． Annu Rev Pharmacol Toxicol， 2009(49): 395-426.DOI: 10.1146/annurev.pharmtox.48.113006.094928. |
| [37] |
Vazquez G, Wedel BJ, Aziz O，et al.The mammalian TRPC cation channels[J]． Biochim Biophys Acta， 2004， 1742(1-3): 21-36.DOI: 10.1016/j.bbamcr.2004.08.015. |
| [38] |
Bon RS, Beech DJ.In pursuit of small molecule chemistry for calcium-permeable non-selective TRPC channels-mirage or pot of gold？[J]． Br J Pharmacol， 2013， 170(3): 459-474.DOI: 10.1111/bph.12274. |
| [39] |
Li HS, Xu XZ, Montell C．Activation of a TRPC3-dependent cation current through the neurotrophin BDNF[J]． Neuron， 1999， 24(1): 261-273.DOI: 10.1016/s0896-6273(00)80838-7. |
| [40] |
Kato AS, Knierman MD, Siuda ER，et al.Glutamate receptor δ2 associates with metabotropic glutamate receptor 1 (mGluR1), protein kinase Cγ，and canonical transient receptor potential 3 and regulates mGluR1-mediated synaptic transmission in cerebellar Purkinje neurons[J]． J Neurosci， 2012， 32(44): 15296-15308.DOI: 10.1523/JNEUROSCI.0705-12.2012. |
| [41] |
Lauderdale K, Murphy T, Tung T，et al.Osmotic edema rapidly increases neuronal excitability through activation of NMDA receptor-dependent slow inward currents in juvenile and adult hippocampus[J]． ASN Neuro， 2015， 7(5): 1759091415605115.DOI: 10.1177/1759091415605115. |
| [42] |
Sun D, Ma H, Ma J，et al.Canonical transient receptor potential channel 3 contributes to febrile seizure inducing neuronal cell death and neuroinflammation[J]． Cell Mol Neurobiol， 2018， 38(6): 1215-1226.DOI: 10.1007/s10571-018-0586-5. |
| [43] |
Liang C, Chen X, Zhang CQ，et al.Expression of TRPC3 in cortical lesions from patients with focal cortical dysplasia[J]． Neurosci Lett， 2020(724): 134880.DOI: 10.1016/j.neulet.2020.134880. |
| [44] |
Zheng DH, Guo W, Sun FJ，et al.Expression of TRPC6 and BDNF in cortical lesions from patients with focal cortical dysplasia[J]． J Neuropathol Exp Neurol， 2016， 75(8): 718-730.DOI: 10.1093/jnen/nlw044. |
| [45] |
|
| [46] |
Zimmer TS, Ciriminna G, Arena A，et al.Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations[J]． Neuropathol Appl Neurobiol， 2020， 46(6): 546-563.DOI: 10.1111/nan.12596. |
| [47] |
Arena A, Zimmer TS, van Scheppingen J，et al.Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence[J]． Brain Pathol， 2019， 29(3): 351-365.DOI: 10.1111/bpa.12661. |
| [48] |
Zhang Z, Liu Q, Liu M，et al. Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type Ⅱ[J]． J Neuroinflammation， 2018， 15(1): 27.DOI: 10.1186/s12974-018-1078-8. |
| [49] |
Srivastava A, Dixit AB, Paul D, et al. Comparative analysis of cytokine/chemokine regulatory networks in patients with hippocampal sclerosis (HS) and focal cortical dysplasia (FCD)[J]． Sci Rep， 2017， 7(1): 15904.DOI: 10.1038/s41598-017-16041-w. |
| [50] |
Jung T, Grune T．The proteasome and the degradation of oxidized proteins：part I-structure of proteasomes[J]． Redox Biol， 2013， 1(1): 178-182.DOI: 10.1016/j.redox.2013.01.004. |
| [51] |
van Scheppingen J, Broekaart DW, Scholl T，et al.Dysregulation of the (immuno)proteasome pathway in malformations of cortical development[J]． J Neuroinflammation， 2016， 13(1): 202.DOI: 10.1186/s12974-016-0662-z. |
| [52] |
He JJ, Li S, Shu HF，et al.The interleukin 17 system in cortical lesions in focal cortical dysplasias[J]． J Neuropathol Exp Neurol， 2013， 72(2): 152-163.DOI: 10.1097/NEN.0b013e318281262e. |